BSX
Boston Scientific Corporation · Healthcare · Medical Devices
TECHStrong SellZACKSSell
R500#451 today
$42.60
-1.46% today · -3.01% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- BSX −1.46% on the last session vs SPY +0.74%: −2.2 pts of stock-specific move.
- Aftermath, 52-week low (Oct 2): After its 5 new 52-week lows in the past 5 years, BSX typically gained 1.1% over the next day (median) and was higher 60% of the time; half the outcomes fell between -0.6% and +1.1%. An ordinary day: +0.1%. Among S&P 500 stocks after new 52-week lows, that ranks #46 of 272. (Low confidence: few independent periods.)
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 28
Before the open · in 24 days
EPS estimate
$0.76
$0.58 to $0.84 · 22 analysts
Revenue estimate
$5.1B
$4.7B to $5.3B
Track record
8/8 beats
last 8 reports · moved ±5.1% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 BMO | 2Q2026 | $0.83 | $0.86 | +$0.03 (+3.9%) beat | $5.4B | 0.0% +1.5 vs SPY | -7.4% | +6.6% |
| Apr 22, 2026 BMO | 1Q2026 | $0.79 | $0.80 | +$0.01 (+1.6%) beat | $5.2B | +9.0% +8.0 vs SPY | +5.0% | -1.8% |
| Feb 4, 2026 BMO | 4Q2025 | $0.78 | $0.80 | +$0.02 (+2.4%) beat | $5.3B | -17.6% -17.1 vs SPY | -11.2% | -19.0% |
| Oct 22, 2025 BMO | 3Q2025 | $0.71 | $0.75 | +$0.04 (+5.1%) beat | $5.1B | +4.0% +4.5 vs SPY | +3.2% | +1.1% |
| Jul 23, 2025 BMO | $0.73 | $0.75 | +$0.02 (+2.7%) beat | — | +4.5% +3.6 vs SPY | +3.8% | +3.2% | |
| Apr 23, 2025 BMO | $0.67 | $0.75 | +$0.08 (+11.9%) beat | — | +4.1% +2.5 vs SPY | +5.2% | +8.1% | |
| Feb 5, 2025 BMO | $0.66 | $0.70 | +$0.04 (+6.1%) beat | — | +1.4% +1.0 vs SPY | -0.6% | +2.4% | |
| Oct 23, 2024 BMO | $0.59 | $0.63 | +$0.04 (+6.8%) beat | — | -0.6% +0.3 vs SPY | -3.1% | -3.9% | |
| Jul 24, 2024 BMO | $0.58 | $0.62 | +$0.04 (+6.9%) beat | — | -1.1% +1.2 vs SPY | -2.5% | -5.8% | |
| Apr 24, 2024 BMO | $0.51 | $0.56 | +$0.05 (+9.8%) beat | — | +5.7% +5.7 vs SPY | +6.0% | +4.2% | |
| Jan 31, 2024 BMO | $0.51 | $0.55 | +$0.04 (+7.8%) beat | — | +3.0% +4.6 vs SPY | +4.2% | +5.5% | |
| Oct 26, 2023 BMO | $0.48 | $0.50 | +$0.02 (+4.2%) beat | — | -0.4% +0.8 vs SPY | +1.5% | +3.3% | |
| Jul 27, 2023 BMO | $0.49 | $0.53 | +$0.04 (+8.2%) beat | — | +0.5% +1.1 vs SPY | +1.5% | -3.4% | |
| Apr 26, 2023 BMO | $0.43 | $0.47 | +$0.04 (+9.3%) beat | — | 0.0% +0.4 vs SPY | +3.1% | +3.5% | |
| Feb 1, 2023 BMO | $0.47 | $0.45 | −$0.02 (−4.3%) miss | — | +2.8% +1.7 vs SPY | +0.8% | +4.0% | |
| Oct 26, 2022 BMO | $0.44 | $0.43 | −$0.01 (−2.3%) miss | — | +1.2% +1.9 vs SPY | +1.6% | +3.5% | |
| Jul 27, 2022 BMO | $0.42 | $0.44 | +$0.02 (+4.8%) beat | — | +6.2% +3.6 vs SPY | +7.0% | +9.2% | |
| Apr 27, 2022 BMO | $0.39 | $0.39 | $0.00 (0.0%) in line | — | +1.1% +0.8 vs SPY | +2.2% | -1.9% | |
| Feb 2, 2022 BMO | $0.44 | $0.45 | +$0.01 (+2.3%) beat | — | -4.7% -5.7 vs SPY | -3.9% | +1.5% | |
| Oct 27, 2021 BMO | $0.40 | $0.41 | +$0.01 (+2.5%) beat | — | -1.3% -0.9 vs SPY | +1.8% | -2.5% | |
| Jul 27, 2021 BMO | $0.37 | $0.40 | +$0.03 (+8.1%) beat | — | — | — | — | |
| Apr 28, 2021 BMO | $0.31 | $0.37 | +$0.06 (+19.4%) beat | — | — | — | — | |
| Feb 3, 2021 BMO | $0.31 | $0.23 | −$0.08 (−25.8%) miss | — | — | — | — | |
| Oct 28, 2020 BMO | $0.25 | $0.37 | +$0.12 (+48.0%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $0.76 (22) | $0.58 – $0.84 | +1% | -9.3% | ▲0 ▼7 | $5.1B | +1% |
| Next quarter · Dec 31, 2026 | $0.84 (21) | $0.82 – $0.91 | +5% | -6.3% | ▲1 ▼3 | $5.4B | +2% |
| Current year · Dec 31, 2026 | $3.26 (25) | $3.16 – $3.37 | +7% | -2.9% | ▲0 ▼8 | $21.2B | +6% |
| Next year · Dec 31, 2027 | $3.41 (26) | $3.19 – $3.90 | +4% | -8.3% | ▲0 ▼8 | $22.2B | +5% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.